Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome

Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics

(2011) Heli J. Lehtonen   Familial Cancer

Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma

(2011) B. Gardie et al.   JOURNAL OF MEDICAL GENETICS

Genetics of Familial Renal Cancers

(2010) Eamonn R. Maher   NEPHRON EXPERIMENTAL NEPHROLOGY

Impact of Genetics on the Diagnosis and Treatment of Renal Cancer

(2010) Eric A. Singer et al.   Current Urology Reports

Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer?

(2009) S. Badeloe et al.   BRITISH JOURNAL OF DERMATOLOGY

No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome

(2009) Pia Vahteristo et al.   Familial Cancer

Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient

(2009) Ismail Alrashdi et al.   Familial Cancer

SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis

(2009) Alex Henderson et al.   Familial Cancer

Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations inSDHBandSDHD

(2009) Christopher J. Ricketts et al.   HUMAN MUTATION

Genetic Basis of Bilateral Renal Cancer: Implications for Evaluation and Management

(2009) W. Marston Linehan   JOURNAL OF CLINICAL ONCOLOGY

The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency

(2008) Jean-Pierre Bayley et al.   BMC Medical Genetics